RxDoctor Payments Data

Donald Fuller, MD

Radiation Oncology · San Diego, CANPI 1285632711

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $27,403 of the $34,321 with a category attached, or 79.8%. 28 manufacturers reported payments, led by Accuray Incorporated at 45.9% of the total. Reporting peaked in 2022 at $22,947 and has fallen 98.6% since, to $311 in 2025. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,321in general payments, 2019–2025

Across 111 payments — averaging $309.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Accuray Incorporated$16K
  • Myovant Sciences Inc.$13K
  • Blue Earth Diagnostics$3K
  • Medtronic$592
  • Siemens Medical Solutions USA, Inc.$319
  • Telix Pharmaceuticals$299
  • plus $1K from 22 others
$2,250in research payments, 2019–2025

Across 2 payments — averaging $1125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Accuray Incorporated$2K

What the payments were for

  • Consulting fees$1,6545%
  • Speaking & faculty fees$27,40380%
  • Travel & lodging$1,7555%
  • Food & beverage$3,50510%
  • Education$40%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,321 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$917,408
Medicare patients
339
Services billed
2,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl231$3,491
Methylprednisolone37$247
Ciprofloxacin Hcl28$78
Lorazepam11$25

Paid to pharmacies, not to this prescriber.

Other radiation oncology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →